Data Characteristics for this Category
siRNA nucleic acid drug data primarily originates from scientific literature (e.g., PubMed, patent databases), clinical trial reports, drug inserts, internal pharmaceutical R&D documents, and regulatory approval documents. The update frequency for this data is relatively low, typically occurring with new research findings, clinical trial progress, or drug approvals, which can range from months to years. Document structures are often semi-structured or unstructured text, containing extensive specialized terminology, biomolecular sequence information, experimental methods, pharmacological mechanisms of action, side effects, dosage, and administration routes. Common fields and units include target gene names, siRNA sequences, chemical modification types, delivery systems, IC50/EC50 values (in nM or µM), cell lines, animal models, clinical phases, and adverse event rates. Sequence information and various biological activity values are unique and critical components.
Constraints Imposed by These Characteristics on Vector Models and Indexing
The biological sequences and complex pharmacological descriptions in siRNA nucleic acid drug data demand high semantic understanding from vector models. General vector models may struggle to effectively capture subtle differences between short sequences and their biological significance, or accurately distinguish the impact of different chemical modifications on drug efficacy. Therefore, vector models require a deep understanding of specialized knowledge in the biomedical field. The low document update frequency means that after initial index construction, the need for incremental updates is not high. However, each update may involve replacing or adding large blocks of text, requiring efficient index reconstruction or update mechanisms. The presence of numerous specialized terms and numerical values requires the tokenizer to correctly identify compound words and proper nouns, preventing sequences or numerical values from being split apart. Additionally, variations in document sources and formats necessitate a unified preprocessing pipeline to ensure the quality and consistency of text input into the vector model, such as standardizing IC50 value units.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500–800 characters (characters) | siRNA mechanisms of action and experimental data descriptions typically concentrate within a few hundred characters. Segments that are too long dilute key information, while segments that are too short may break logical coherence. |
Chunk Overlap Length (Segment Overlap Length) | 50 characters (characters) | Ensures sufficient contextual connection between adjacent segments, especially when explaining pathways or experimental procedures. |
Recall count (Recall Count) | 8–12 entries (items) | siRNA consultations often require synthesizing information from multiple sources. Appropriately increasing the recall count enhances comprehensiveness and avoids missing critical details. |
Similarity threshold (Similarity Threshold) | Calibrate by actual measurement (Calibrated by actual measurement) | Requires testing against the specific vector model and dataset to ensure that highly relevant and discriminative results are recalled. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | When processing large clinical reports or patent documents, parsing time can be long. This reserves sufficient timeout duration. |
maxContext | 3000 Tokens | Addresses queries involving complex experimental data, multi-sequence comparisons, or detailed pharmacological mechanism descriptions. |
Three Common Mistakes
- After importing data, the status remains "creating index" for an extended period. This may occur because the default parser lacks sufficient performance or the timeout setting is too short when processing large volumes of PDF files containing complex tables or biological sequences.
- Vector calculation scores show unusually large and highly consistent values. This may stem from ineffective cleaning of special characters or encoding issues in the text during the preprocessing stage, leading to the vectorization model failing to operate correctly.
- Vectorization speed is slow after uploading documents to the knowledge base. This may be due to insufficient server resources (CPU/RAM) to support high-concurrency vector calculation tasks, especially when processing multiple large files.
How to Confirm Proper Configuration
- Upload documents containing siRNA sequences, target genes, and efficacy data points. Verify that the Q&A results accurately extract and associate this key information.
- For different query types (e.g., mechanism inquiries, side effect queries, sequence comparisons), evaluate the relevance of recall results through test queries and adjust the
Similarity threshold(Similarity Threshold). - Check system logs to confirm that no
PARSE_FILE_TIMEOUT_SECONDSrelated errors occur when processing large documents, and that index creation tasks complete successfully. - Randomly select documents from the knowledge base and verify that key paragraphs are correctly segmented and that the segmented content maintains semantic integrity.
Note: The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.